Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Should iShares Top 20 U.S. Stocks ETF (TOPT) Be on Your Investing Radar?
posted:
Thu, 10/01/2026 - 05:20 EDT
by:
Nasdaq Technology
#channels::
#All
,
#Business
,
#Nasdaq
,
#Technology
,
#NasdaqTechnology
,
#Stocks
3 Key Reasons to Buy This Huge Turnaround Story That's Gaining Traction
posted:
Thu, 10/01/2026 - 05:20 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Microsoft’s Trillion-Dollar Quarter Powered by Ravenous AI Trade
posted:
Thu, 10/01/2026 - 05:19 EDT
by:
Bloomberg BusinessWeek
#channels::
#All
,
#Business
,
#Technology
,
#Bloomberg
,
#BloombergBusinessWeek
,
#Stocks
Is Wall Street Dead Wrong About Intuitive Surgical? Here's My Honest Answer.
posted:
Thu, 10/01/2026 - 05:04 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Russia’s Grain Rerouting Falls Short as War Roils Black Sea
posted:
Thu, 10/01/2026 - 05:03 EDT
by:
Bloomberg Daybreak
#channels::
#All
,
#Business
,
#Bloomberg
,
#BloombergDaybreak
,
#Stocks
$500 a Month in Vanguard's Total Stock Market ETF Since 2001 Grew to About $876,000
posted:
Thu, 10/01/2026 - 05:03 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Pfizer's Tilrekimig Delivers Significant Skin Clearance In Phase 2 Atopic Dermatitis Study
posted:
Thu, 10/01/2026 - 04:57 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Zimbabwe’s Payments to Former White Farmers Reach $508 Million
posted:
Thu, 10/01/2026 - 04:49 EDT
by:
Bloomberg Daybreak
#channels::
#All
,
#Business
,
#Bloomberg
,
#BloombergDaybreak
,
#Stocks
History Says October Is the Stock Market's Most Dangerous Month. Here's My Defensive Playbook.
posted:
Thu, 10/01/2026 - 04:40 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Uh-Oh! The Latest September Inflation Forecast Spells Trouble for Wall Street, and It's Not Just Energy Prices to Blame.
posted:
Thu, 10/01/2026 - 04:26 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Zealand Pharma: Boehringer's Survodutide Meets Phase 3 Endpoints In Obesity & Diabetes Trial
posted:
Thu, 10/01/2026 - 04:04 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Genentech's Giredestrant Posts Positive Phase 3 Data Ahead Of November, December FDA Dates
posted:
Thu, 10/01/2026 - 04:01 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Michael Burry's New Bet Against Micron Stock Expires in June 2027. I Think His Timing Is Off.
posted:
Thu, 10/01/2026 - 03:57 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Lundbeck's Phase IV Trial Of Eptinezumab Meets Primary Goal In Migraine After Prior CGRP Therapy
posted:
Thu, 10/01/2026 - 03:52 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
If I Had $10,000 to Invest Today, Here's the Growth Stock I'd Buy Instead of SpaceX
posted:
Thu, 10/01/2026 - 03:49 EDT
by:
Nasdaq NFLX NetFlix
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#NFLX
,
#NetFlix
Pagination
Previous page
‹‹
Page 11
Next page
››